Pdl Biopharma Inc (PDLI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 2,103 | 6,617 | -68,859 | -85,138 | -110,694 |
| Depreciation Amortization | 6,409 | 3,221 | 27,136 | 23,060 | 18,616 |
| Income taxes - deferred | 9,353 | -602 | 13,846 | -3,285 | -11,276 |
| Accounts receivable | -3,532 | 1,472 | 9,349 | 15,752 | 11,709 |
| Accounts payable and accrued liabilities | 1,078 | -65 | -6,642 | -10,774 | -8,679 |
| Other Working Capital | 3,750 | 2,382 | -23,218 | -13,778 | -23,553 |
| Other Operating Activity | 1,520 | -15,328 | 34,963 | 62,804 | 104,121 |
| Operating Cash Flow | $20,681 | $-2,303 | $-13,425 | $-11,359 | $-19,756 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -163 | -42 | -4,523 | -4,641 | -3,915 |
| Sale Of Investment | N/A | N/A | 4,116 | 4,116 | 4,116 |
| Purchase Sale Intangibles | -1,700 | N/A | 57,969 | 37,049 | 37,993 |
| Other Investing Activity | -28,974 | 0 | 57,111 | 37,049 | 37,993 |
| Investing Cash Flow | $-29,137 | $-42 | $56,704 | $36,524 | $38,194 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | -126,447 | -126,447 | -126,447 |
| Common Stock Repurchased | -71,266 | -44,288 | -49,109 | -25,000 | -23,604 |
| Dividend Paid | N/A | N/A | -48 | N/A | N/A |
| Other Financing Activity | -1,071 | -1,071 | -351 | 0 | 0 |
| Financing Cash Flow | $-72,337 | $-45,359 | $-175,955 | $-151,447 | $-150,051 |
| Beginning Cash Position | 394,590 | 394,590 | 527,266 | 527,266 | 527,266 |
| End Cash Position | 342,244 | 346,886 | 394,590 | 400,984 | 395,653 |
| Net Cash Flow | $-52,346 | $-47,704 | $-132,676 | $-126,282 | $-131,613 |
| Free Cash Flow | |||||
| Operating Cash Flow | 20,681 | -2,303 | -13,425 | -11,359 | -19,756 |
| Capital Expenditure | -163 | -42 | -4,523 | -4,641 | -3,915 |
| Free Cash Flow | 20,518 | -2,345 | -17,948 | -16,000 | -23,671 |